Related Experiment Video

Updated: Aug 30, 2026

Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

The molecular basis of skeletal metastases

Peter F M Choong1

  • 1Department of Orthopaedics, The University of Melbourne, St Vincent's Hospital, Melbourne, Australia. sarcomasurgeopn@ozemail.com.au

Insights

Metastasis involves cell migration and proliferation, leading to bone damage. Understanding these molecular processes is key to developing new therapies targeting cancer spread.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pathology

Background:

  • Metastasis is a complex, multi-step process involving cancer cell proliferation and migration.
  • Skeletal metastasis causes bone sclerosis or osteolysis, leading to pain, fractures, and metabolic issues.
  • Targeting metastasis is challenging due to the numerous biological systems involved.

Purpose of the Study:

  • To review recent advances in understanding the molecular mechanisms of metastasis.
  • To identify potential therapeutic targets for preventing or reducing cancer spread.
  • To explore novel agents and therapies for combating metastasis.

Main Methods:

  • Review of current scientific literature on molecular metastasis.
  • Analysis of functional mechanisms involved in cancer cell adhesion, invasion, and migration.
  • Examination of interactions with endothelial cells and growth factor regulation.

Main Results:

  • Identified key functional mechanisms in metastasis: adhesion, invasion, migration, endothelial interactions, growth factor regulation, proteolysis, and osteoblast/osteoclast stimulation.
  • Highlighted the complexity arising from numerous systems, substrates, ligands, receptors, factors, and pathways.
  • Recent advances reveal potential molecular sites and substrates for therapeutic intervention.

Conclusions:

  • Targeting the molecular processes of metastasis offers promising avenues for novel cancer therapies.
  • Further research into these mechanisms can lead to strategies to prevent or mitigate cancer spread.
  • Developing effective therapies requires a comprehensive understanding of the intricate molecular pathways governing metastasis.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...